Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
This study has been completed.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Information provided by:
First received: November 5, 2008
Last updated: August 9, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2011|
|Primary Completion Date:||May 2011 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||May 15, 2012|